Myopia and Presbyopia Treatment Market Analysis

Disease Type Segment Analysis

Myopia is the leading disease type segment and is expected to hold the share value of 60.4% by 2035. The segment is fueled by rising global prevalence, mainly in the Asia-Pacific region. According to the WOO University report in 2021, nearly 30% of the overall population in the world are myopic. Further, the prevalence of myopia is mostly seen in South Korea, Singapore, Taiwan, and Southeast Asia. This epidemic-scale growth directly fuels the demand for corrective and management treatments, from spectacles to advanced surgical and pharmaceutical interventions.

Age Group Segment Analysis

In the age group segment, the adult age group age between 18 and 64 is projected to hold the dominant share by 2035. This demographic encompasses the vast majority of individuals who actively seek vision corrective solutions for myopia progression and the onset of presbyopia. As per the Indian Journal of Ophthalmology published in August 2022, nearly 80% of the population is suffering from myopia. This data shows the high prevalence of myopia among people in the age range 18 to 64, underscoring early onset and the growing burden of myopia in children and adolescents.

End user Segment Analysis

Ambulatory Surgical Centers are holding the greatest share in the end user, and are driven by their efficiency, cost-effectiveness, and maximum patient preference for outpatient services. Procedures such as cataract surgery (with premium IOLs for presbyopia) and refractive surgeries offer high-tech services in ASCs for the outpatient sector to reduce the healthcare burden costs. This trend is aided by government policies favoring outpatient services to minimize healthcare burdens. The Centers for Medicare & Medicaid Services (CMS) regularly revises reimbursement policies for services in ASCs, promoting their use and fueling market revenue.

Our in-depth analysis of the global market includes the following segments: